[1]杨松,周旭,刘敬禹,等.国产药物洗脱支架（Bridge）在颅内前循环血管狭窄中的应用[J].中国临床神经外科杂志,2023,28(08):497-499.[doi:10.13798/j.issn.1009-153X.2023.08.006]
　YANG Song,ZHOU Xu,LIU Jing-yu,et al.Application of domestic rapamycin eluting stents (Bridgein) in patients with anterior circulation intra-cranial stenosis[J].,2023,28(08):497-499.[doi:10.13798/j.issn.1009-153X.2023.08.006]
点击复制

国产药物洗脱支架（Bridge）在颅内前循环血管狭窄中的应用()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年08期
页码:
497-499
栏目:
论著
出版日期:
2023-08-31

文章信息/Info

Title:
Application of domestic rapamycin eluting stents (Bridgein) in patients with anterior circulation intra-cranial stenosis
文章编号:
1009-153X（2023）08-0497-03
作者:
杨松; 周旭; 刘敬禹; 王立辉; 陈森; 聂文; 徐增良; 纪德峰; 宋海涛
266100山东青岛，同济大学附属东方医院胶州医院神经外科（杨松、陈森、聂文、徐增良、纪德峰、宋海涛），介入科（周旭、刘敬禹、王立辉）
Author(s):
YANG Song1;  ZHOU Xu2;  LIU Jing-yu2;  WANG Li-hui2;  CHEN Sen1;  NIE Wen1;  XU Zeng-liang1;  JI De-feng1;  SONG Hai-tao1
1. Department of Neurosurgery, Jiaozhou Branch, Dongfang Hospital, Tongji University, Qingdao 266100, China; 2. Department of Intervention, Jiaozhou Branch, Dongfang Hospital, Tongji University, Qingdao 266100, China
关键词:
颅内动脉粥样硬化性狭窄; 颅内前循环; 支架置入术; Enterprise Ⅱ支架; Bridge支架; 药物洗脱支架; 疗效
Keywords:
Anterior circulation intracranial stenosis;  Enterprise Ⅱ stent;  Rapamycin drug-eluting stent;  Bridgein stent;  Efficacy
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2023.08.006
文献标志码:
R 743.9; R 815.2
摘要:
目的 探讨国产雷帕霉素药物洗脱支架（Bridge）在颅内前循环狭窄中的应用效果。方法 2022年1月至2022年9月前瞻性收治颅内前循环血管狭窄55例，按入院顺序给予Enterprise Ⅱ支架（29例）或雷帕霉素药物洗脱支架（Bridge，26例）治疗。术后6个月DSA随访，评估再狭窄率和脑梗塞（脑血栓形成）等，术后6个月采用改良Rankin量表（mRS）评分评估预后。结果 55例手术成功率为100.0%，围手术期未发生颅内出血、支架内血栓形成、动脉夹层等。Enterprise组2例因大脑中动脉M1段狭窄致急性脑栓塞再次介入手术，术后6个月mRs评分4分，其余27例mRS评分0~1分；3例术后发现再狭窄。Bridge组1例双侧支架置入术后2个月出现一侧急性脑栓塞，术后6个月mRS评分5分，其余25例术后6个月mRS评分0分。两组术后并发症发生率、术后6个月mRS评分无统计学差异（P>0.05）。结论 Bridge支架在颅内前循环血管狭窄中应用效果良好，但是需要充分评估病人的血管条件，在颈内动脉海绵窦段过度迂曲病人中可能需要使用长鞘及中间导管，增加手术难度与手术时间。
Abstract:
Objective To investigate the clinical efficacy of domestic rapamycin drug-eluting stents (Bridge) for patients with anterior circulation intracranial stenosis. Methods Fifty-five patients with anterior circulation intracranial stenosis were prospectively recruited from January 2022 to September 2022. Twenty-nine patients received Enterprise Ⅱ stent implantation (Enterprise group) and 26 patients received rapamycin drug-eluting stent (Bridgein group) implantation according to the order of admission. The rate of restenosis and cerebral infarction were evaluated by DSA follow-up 6 months after the operation. The prognosis was evaluated using the modified Rankin scale (mRS) score 6 months after the operation. Results The success rate of 55 patients was 100.0%. There was no intracranial hemorrhage, stent thrombosis or arterial dissection during the perioperative period. In the Enterprise group, 2 patients suffered from acute cerebral embolism due to middle cerebral artery M1 stenosis who received re-intervention treatment and had a mRS sore of 4 at 6 months after the operation, and the other 27 patients had a mRS score of 0~1 at 6 months after the operation; restenosis occurred in 3 patients. In the Bridge group, 1 patient had acute cerebral embolism 2 months after bilateral stent implantation and had a mRS score of 5 at 6 months after the surgery, and the other 25 patients had a mRS score of 0 at 6 months after the surgery. Conclusions Bridge stent is effective in the treatment of patients with anterior circulation intracranial stenosis, but the patient's vascular conditions need to be fully evaluated before the operation. Long sheath and intermediate catheter should be used in patients with excessive tortuosity of the cavernous (C4) segment of the internal carotid artery, which may increase the difficulty and time of surgery.

参考文献/References:

[1]JUNG JM, KANG DW, YU KH, et al. Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis [J]. Stroke, 2012. 43(10): 2785-2787.
[2]WANG Y, MENG R, LIU G, et al. Intracranial atherosclerotic disease [J]. Neurobiol Dis, 2019, 124: 118-132.
[3]HAFEEZ A, LIU L, DING Y. Ongoing progress and new developments in the clinical approach to stroke and cerebrovascular disease: new paradigms: a novel outlook into stroke [J]. Neurol Res, 2016, 38(6): 477.
[4]陈康宁. 症状性动脉粥样硬化性椎动脉起始部狭窄血管内治疗中国专家共识[J]. 中华医学杂志，2015，95（9）：648-653.
[5]缪中荣，凌　锋，李慎茂，等. 支架辅助血管成形术在症状性颅内动脉狭窄治疗中的应用[J]. 中华医学杂志，2002，82（10）：657-660.
[6]王圣杰，刘俊中，尹帅领，等. 颅内动脉粥样硬化性狭窄Enterprise支架置入术后支架内再狭窄的危险因素分析[J]. 中国临床神经外科杂志，2023，28（1）：5-7，56.
[7]凌一童，孙玉杰，李广文，等. 雷帕霉素洗脱支架与金属裸支架治疗症状性颅内动脉粥样硬化性狭窄的效果比较[J]. 中国卒中杂志，2022，17（5）：529-534.
[8]ZHANG Y, CHEN F, MURAMATSU T, et al. Nine-month angiographic and two-year clinical follow-up of polymerfree sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial [J]. Chin Med J (Engl), 2014, 127(11): 2153-2158.
[9]QURESHI AI, KIRMANI JF, HUSSEIN HM, et al. Early and intermediate-term outcomes with drug-eluting stents in highrisk patients with symptomatic intracranial stenosis [J]. Neurosurgery, 2006, 59(5): 1044-1051.
[10]KIM J, BAN SP, KIM YD, et al. Long-term outcomes of drug-eluting stent implantation in patients with symptomatic extra- and intracranial atherosclerotic stenoses [J]. J Cerebrovasc Endovasc Neurosurg, 2020, 22(4): 216-224.
[11]HASSAN AE, MOHAMMADEN MH, RABAH RR, et al. Initial experience with the next-generation resolute onyx zotarolimus-eluting stent in symptomatic intracranial atherosclerotic disease [J]. Front Neurol, 2020, 11: 570100.
[12]钟旋旋，于挺敏. 214例急性缺血性卒中病人抗血小板药物反应性的观察及影响因素的探究[J]. 中国实验诊断学，2020，24（1）：17-20.

相似文献/References:

[1]韩冰莎　李　娇　李　翔　栗艳茹　张　磊　赵敬河　冯　光.脑氧饱和度监测目标导向治疗在前循环急性缺血性脑卒中机械取栓术后管理的效果[J].中国临床神经外科杂志,2020,(02):73.[doi:10.13798/j.issn.1009-153X.2020.02.004]
　HAN Bing-sha,LI Jiao,LI Xiang,et al.Effects of targeted therapy under direction of monitoring cerebral oxygen saturation on patients with acute ischemic stroke of anterior circulation undergoing mechanical thrombectomy[J].,2020,(08):73.[doi:10.13798/j.issn.1009-153X.2020.02.004]
[2]李振宇　孟华星　李作鹏　张　金.麻醉方式对不配合的急性颅内前循环闭塞病人机械取栓术的影响[J].中国临床神经外科杂志,2020,(05):280.[doi:10.13798/j.issn.1009-153X.2020.05.008]
　LI Zhen-yu,MENG Hua-xing,LI Zuo-peng,et al.Effect of anesthesia on mechanical thrombectomy in uncooperative patients with acute anterior circulation occlusion[J].,2020,(08):280.[doi:10.13798/j.issn.1009-153X.2020.05.008]
[3]王圣杰,刘俊中,尹帅领,等.颅内动脉粥样硬化性狭窄Enterprise支架置入术后支架内再狭窄的危险因素分析[J].中国临床神经外科杂志,2023,28(01):5.[doi:10.13798/j.issn.1009-153X.2023.01.002]
　WANG Sheng-jie,LIU Jun-zhong,YIN Shuai-ling,et al.Risk factors for in-stent restenosis in patients with intracranial atherosclerotic stenosis after Enterprise stenting[J].,2023,28(08):5.[doi:10.13798/j.issn.1009-153X.2023.01.002]

备注/Memo

备注/Memo:
（2023-01-10收稿，2023-07-20修回）
通讯作者：宋海涛，E-mail：haitao3058@126.com
更新日期/Last Update: 2022-08-31